232 related articles for article (PubMed ID: 24411029)
1. Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Chen FP
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):475-8. PubMed ID: 24411029
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
[TBL] [Abstract][Full Text] [Related]
5. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Tranoulis A; Laios A; Mitsopoulos V; Lutchman-Singh K; Thomakos N
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():129-136. PubMed ID: 28985547
[TBL] [Abstract][Full Text] [Related]
7. Detection of Human Papillomavirus Infection in Patients with Vaginal Intraepithelial Neoplasia.
Lamos C; Mihaljevic C; Aulmann S; Bruckner T; Domschke C; Wallwiener M; Paringer C; Fluhr H; Schott S; Dinkic C; Brucker J; Golatta M; Gensthaler L; Eichbaum M; Sohn C; Rom J
PLoS One; 2016; 11(12):e0167386. PubMed ID: 27907089
[TBL] [Abstract][Full Text] [Related]
8. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
Yu D; Qu P; Liu M
J Obstet Gynaecol Res; 2021 May; 47(5):1624-1630. PubMed ID: 33754436
[TBL] [Abstract][Full Text] [Related]
10. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
11. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
[TBL] [Abstract][Full Text] [Related]
13. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
Tainio K; Jakobsson M; Louvanto K; Kalliala I; Paavonen J; Nieminen P; Riska A
Int J Cancer; 2016 Nov; 139(10):2353-8. PubMed ID: 27428506
[TBL] [Abstract][Full Text] [Related]
15. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
16. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V; Carcopino X; Preti M; Vieira-Baptista P; Bevilacqua F; Bornstein J; Chargari C; Cruickshank M; Erzeneoglu E; Gallio N; Gultekin M; Heller D; Joura E; Kyrgiou M; Madić T; Planchamp F; Regauer S; Reich O; Esat Temiz B; Woelber L; Zodzika J; Stockdale C
Int J Gynecol Cancer; 2023 Apr; 33(4):446-461. PubMed ID: 36958755
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
[TBL] [Abstract][Full Text] [Related]
18. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the Management of Vaginal Intraepithelial Neoplasia.
Kesic V; Carcopino X; Preti M; Vieira-Baptista P; Bevilacqua F; Bornstein J; Chargari C; Cruickshank M; Erzeneoglu E; Gallio N; Gultekin M; Heller D; Joura E; Kyrgiou M; Madić T; Planchamp F; Regauer S; Reich O; Esat Temiz B; Woelber L; Zodzika J; Stockdale C
J Low Genit Tract Dis; 2023 Apr; 27(2):131-145. PubMed ID: 36951985
[TBL] [Abstract][Full Text] [Related]
19. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
